Abstract
The present disclosure relates to a higher-throughput, mid-scale, semi-automated protein expression and screening platform that can be used, for instance, for drug discovery research and otherwise for testing protein expression conditions, among other uses. The workflow described here also in some embodiments enables comprehensive expression and purification screening assessment of challenging or difficult-to-express recombinant proteins in a faster and efficient manner by delivering small but sufficient amounts of high-quality proteins.
Full Text
What is claimed is:
The present disclosure relates to a higher-throughput, mid-scale, semi-automated protein expression and screening platform that can be used, for instance, for drug discovery research and otherwise for testing protein expression conditions, among other uses. The workflow described here also in some embodiments enables comprehensive expression and purification screening assessment of challenging or difficult-to-express recombinant proteins in a faster and efficient manner by delivering small but sufficient amounts of high-quality proteins.
Timeline
Filed
02/27/2026Published
07/02/2026Granted
Not AvailableIPC Codes(3)
C07K 1/34:by filtration, ultrafiltration or reverse osmosis
C07K 1/22:Affinity chromatography or related techniques based upon selective absorption processes
C07K 1/36:by a combination of two or more processes of different types